Category: 3. Business

ISLAMABAD:

A few weeks ago, the name Sualeh Asif coupled with the acronym MIT, began making rounds on social media as people discovered the young man from Pakistan is one of the minds behind Cursor, the AI-powered code editor valued at $9.9 billion, which is taking the AI startup scene by storm.

The Cursor team made its first appearance in Pakistan at a meetup in Islamabad attended by over hundred builders, tech enthusiasts and students eager to take part in the future of programming.

The event was hosted at the National Incubation Centre and featured a live demonstration of Cursor’s build-on-command capabilities by its Pakistan Ambassador, Yahya Qureshi, a talk by Antematter engineer, Zohaib Adnan, on how the product has changed programming at their company and a Q&A session with Cursor developer, Juan Batista Martinez, who joined on zoom.

Cursor allows developers to generate code and build programmes simply by describing what they want it to do. In response, the software prints out ready-to-use lines of code which can be further edited through additional prompts to incorporate new features, fix bugs and more.

“For those unfamiliar with the concept, this is known as vibe coding,” explained the Cursor ambassador, Yahya. “You no longer need to type out thousands of lines of code one by one. You could be out for a walk or driving, and you simply need to have entered a task into Cursor, so that by the time you have reached your destination, your code will be ready,” he added enthusiastically.

Several tech companies, including Taleemabad, Eynvision, and others, showed up to the event, curious about how Cursor can help upgrade their work. “Since using Cursor, our developers at Antematter are spending much less time doing the grunt work and more time innovating and investing energy in coming up with critical solutions,” said Zohaib Adnan as he shared how AI has transformed development.

Cursor developer Juan Martinez echoed the same thoughts when asked about what vibe coding means for the future of engineers in the job market. “AI isn’t here to replace engineers. We need humans for their ability to exercise creativity and think critically,” he said. “Cursor is not about eliminating the work humans do. It’s about what can be achieved when humans work alongside the power of AI.”

Many from the audience posed questions about Cursor’s features and future updates to Juan. Some even shared feedback based on their own experience using the software.

The Cursor team was overwhelmed by the response and the interest shown by the community in Pakistan, with the ambassador saying that he was amazed to see the projects people have been working on using Cursor, which they shared on the Cursor Pakistan WhatsApp group. “This is only the beginning. We plan to host many more meetups, including workshops and hackathons across Pakistan,” announced Yahya.

The attendees expressed their satisfaction at the chance to interact with the Cursor team in Pakistan, while others on social media expressed that they could not wait for a similar event in their cities. “Events like these are a great thing for the tech space in Pakistan,” said a computer science student, Amama. “Opportunities to interact with skilled people in the field are rare for us, so this was very refreshing,” she said.

Treatment with the allogeneic, granulocyte macrophage colony-stimulating factor–secreting vaccine Bria-IMT (SV-BR-1-GM) in combination with immune checkpoint inhibition led to a 1-year overall survival (OS) rate of 52% in patients with heavily pretreated metastatic breast cancer, according to updated data from a phase 2 trial (NCT03328026).¹

This OS rate was achieved in 25 patients with metastatic breast cancer who were treated with the phase 3 formulation of Bria-IMT since 2022. Patients in this group had received a median of 6 prior lines of therapy, and this population included patients with hormone receptor–positive breast cancer (61%), HER2-positive breast cancer (6%), and triple-negative breast cancer (TNBC; 33%).

“Many patients with metastatic breast cancer unfortunately have disease progression despite treatment with checkpoint inhibitors and antibody-drug conjugates,” Aditya Bardia, MD, MPH, FASCO, a professor in the Department of Medicine of the Division of Hematology/Oncology, director of Translational Research Integration, and a member of Signal Transduction and Therapeutics at UCLA Health, stated in a news release. “[The] survival data in [this] single-arm phase 2 trial highlight the potential activity of Bria-IMT in combination with checkpoint inhibitors and is subject to ongoing investigation in a phase 3 randomized clinical trial [NCT06072612] in metastatic breast cancer.”

Previously reported findings from the phase 2 trial showed that treated patients with HR-positive breast cancer (n = 25) achieved a median OS of 17.3 months.² BriaCell Therapeutics cited a historical median OS of 14.4 months for sacituzumab govitecan-hziy (Trodelvy) and 11.3 months for single-agent chemotherapy.

Additionally, in the TNBC subgroup, Bria-IMT plus pembrolizumab yielded a median OS of 11.4 months compared with 11.8 months with the historical control for sacituzumab govitecan and 6.9 months for single-agent chemotherapy.

Phase 2 Trial Overview

Investigators of phase 2 trial enrolled patients at least 18 years of age with histologically confirmed recurrent or metastatic breast cancer whose disease had progressed on prior therapy.³

Patients with metastatic HR-positive, HER2-positive disease were required to be refractory to hormonal therapy and previously treated with at least 2 regimens including at least 2 anti-HER2 agents. Those with HR-positive, HER2-negative breast cancer needed to be refractory to hormonal therapy and previously treated with at least 2 chemotherapy-containing regimens. In those with HR-negative, HER2-positive disease, at least 2 prior anti-HER2 agents were required. Patients with TNBC needed to have exhausted all standard prior therapies, including prior treatment with a taxane and carboplatin.

An ECOG performance status of 0 to 2 and a life expectancy of at least 4 months were necessary for all patients.

All patients received cyclophosphamide given 2 to 3 days prior to Bria-IMT, which was given on day 0. Patients also received interferon at the inoculation sites 2 days (± 1 day) after Bria-IMT. Along with the Bria-IMT regimen, patients were randomly assigned to receive retifanlimab once every 3 weeks starting in cycle 1, or sequential treatment with the first dose of retifanlimab given in cycle 2.

Safety served as the trial’s primary end point. Secondary end points included overall response rate and duration of response.

“BriaCell’s phase 2 data indicate a robust survival signal and a well-tolerated profile,” Adam M. Brufsky, MD, PhD, FACP, a professor of medicine at the University of Pittsburgh School of Medicine and medical director of the Magee-Women’s Cancer Program in Pennsylvania, added in the news release.¹ “These results reinforce BriaCell’s potential to improve survival and tolerability for late-stage patients.”

References

1. BriaCell phase 2 survival achievement: 52% of patients surpass one-year milestone in metastatic breast cancer. News release. BriaCell Therapeutics. https://finance.yahoo.com/news/briacell-phase-2-survival-achievement-113000536.html
2. BriaCell phase 2 survival data beats leading standard in HR+ breast cancer. News release. BriaCell Therapeutics. April 16, 2025. Accessed July 8, 2025. https://briacell.com/briacell-phase-2-survival-data-beats-leading-standard-in-hr-breast-cancer/
3. Combination study of SV-BR-1-GM with retifanlimab. CliniclaTrials.gov. Updated February 4, 2025. Accessed July 8, 2025. https://clinicaltrials.gov/study/NCT03328026

By Tomi Kilgore

ProKidney goes from a penny stock to a $1 billion market cap in very volatile trading, after upbeat data on the biotech’s kidney disease and diabetes treatment

The stock of the day on Tuesday was ProKidney Corp.’s, as it was both the biggest gainer and the most actively traded on major U.S. exchanges, after the biotechnology company’s diabetes treatment produced positive results in a mid-stage trial.

Evercore ISI analyst Jonathan Miller said the results of the Phase 2 trial of rilparencel, for the treatment of chronic kidney disease and diabetes, were “very intriguing.” But he reiterated his in-line rating on the stock, writing, “we still have [questions]” heading into a Phase 3 trial.

And it could be 18 months before data from a Phase 3 trial is released.

The stock (PROK) had closed at 61 cents on Monday, to give ProKidney a market capitalization of about $178.55 million. That was the 17th straight session with a close below $1, and the 46th sub-$1 close over the past 47 sessions.

On Tuesday, the stock blasted 515% higher to close at a 14-month high of $3.73. Trading volume exploded to more than 327.3 million shares as of about 4:15 p.m. Eastern, compared with the full-day average of about 1.3 million shares.

The trading was so active that it was halted 45 times for volatility, between 10:15 a.m. Eastern and the closing bell at 4 p.m.

The company said the Regen-007 Phase 2 trial showed that those treated with rilparencel demonstrated a “robust improvement” in a measure of CKD and diabetes. Chief Executive Bruce Culleton said the data bolsters confidence in the design of the Phase 3 study.

Evercore’s Miller believes the Phase 3 trial in CKD could be a “major catalyst in the kidney space.” However, he said there are still some questions about the nuances of the data, which he “can’t reconcile completely.”

Miller said he there could be a readout on Phase 3 data as early as the end of 2026.

-Tomi Kilgore

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

  (END) Dow Jones Newswires

  07-08-25 1709ET
Copyright (c) 2025 Dow Jones & Company, Inc.

Thank you to the George Washington University Regulatory Studies Center, Roger Nober, Susan Dudley, and the organizers of today’s event for allowing me to join virtually. As many of you are aware, I have spent the last several years engaging regulators and market participants from jurisdictions around the world on issues at the core of today’s discussion.[1]

How might advances in artificial intelligence (AI) increase inclusion and customer experiences and democratize access to financial services, improve the accuracy and efficiency of financial services, and potentially reduce transaction costs as well as the costs of compliance? 

These issues, among several other potential benefits and risks associated with the adoption of innovative technologies, are top of mind for me and many other senior regulators, chief executive officers, chief technology officers, chief information security officers, chief compliance officers, and chief risk managers around the world.

According to an International Monetary Fund paper exploring the benefits and risks of AI in finance, AI and machine learning (ML) technologies alongside other

[r]ecent technological advances in computing and data storage power, big data, and the digital economy are facilitating rapid AI/ML deployment in a wide range of sectors, including finance. The COVID-19 crisis has accelerated the adoption of these systems due to the increased use of digital channels.

AI/ML systems are changing the financial sector landscape. Competitive pressures are fueling rapid adoption of AI/ML in the financial sector by facilitating gains in efficiency and cost savings, reshaping client interfaces, enhancing forecasting accuracy, and improving risk management and compliance. AI/ML systems also offer the potential to strengthen prudential oversight and to equip [regulators]  with new tools. . . .[2]

Indisputably, AI is rapidly transforming the financial sector, particularly in the areas of compliance, market surveillance, and regulatory enforcement. What once seemed the creative imaginings of science fiction or fantasy novels and films—forward-looking notions of a futuristic world—has now become a practical and increasingly essential tool across the financial market ecosystem. Market participants and regulators alike are leveraging AI and ML to improve risk management, detect misconduct, and strengthen the integrity of the markets.

Let’s explore the use of AI in compliance, bad actors’ potential misuse of AI, opportunities for supervisory technology (suptech) in enforcement, and a path forward.

AI and Industry Compliance

Financial institutions have been at the forefront of AI adoption, especially in compliance functions. AI is widely used in anti-money laundering (AML) efforts, where algorithms analyze transaction patterns across millions of credit card statements, bank statements, and account details to detect anomalies that may go unnoticed by traditional systems. ML models have dramatically reduced false positives in AML alerts[3]; this has long been a challenge for compliance teams who may now rely on AI to learn by reviewing training data and distinguish between benign and suspicious activity more precisely and more efficiently.

AI also supports compliance with complex cross-border financial regulations. Financial services firms deploy ML to monitor transactions for potential sanctions violations, helping ensure that transactions align with regulatory requirements based on origin, amount, frequency, and other risk factors.[4]

Some firms have also embraced AI in communications surveillance, using platforms that offer digital communications governance to review internal communications for signs of fraud or misconduct. By automating these reviews, firms are better equipped to identify red flags early and maintain robust compliance programs.

A recent Government Accountability Office (GAO) report released in May of 2025—Artificial Intelligence: Use and Oversight in Financial Services—identifies six increasingly common activities for which financial services firms may choose to integrate AI models, including automated trading, countering threats and illicit finance, credit decisions, customer service, investment decisions, and risk management.[5]

The GAO report indicated that AI may be used to “detect and mitigate cyber threats through real-time investigation of potential attacks, flagging and blocking of new ransomware, and identification of compromised accounts and files” as well as to “identify fake IDs, recognize different photos of the same person, and screen clients against sanctions and other lists; analyze transaction data … and unstructured data (such as email, text, and audio data) to detect evidence of possible money laundering, terrorist financing, bribery, tax evasion, insider trading, market manipulation, and other fraudulent or illegal activities.”[6]

For many of these use cases, financial services firms rely on generative AI. However, for use cases that require a high degree of reliability or explainability—the ability to understand how and why an AI system produces decisions, predictions, or recommendations—firms are rightly reticent to employ generative AI models.

Regulators Use of AI for SupTech 

The benefits of AI are not limited to the private sector. U.S. regulatory agencies—including the Commodity Futures Trading Commission (CFTC), the Board of Governors of the Federal Reserve System (Federal Reserve), the Federal Deposit Insurance Corporation (FDIC), the Securities and Exchange Commission (SEC), and the National Credit Union Administration (NCUA)—have begun integrating AI tools into their supervisory functions.

These agencies use AI to analyze vast quantities of financial data, identify outliers, and detect emerging risks.[7] For example, AI can flag inconsistencies in data submissions from financial institutions, or surface patterns that indicate potential regulatory violations. This use of AI, often referred to as “suptech” (supervisory technology), enhances regulators’ ability to carry out their oversight responsibilities efficiently and proactively.

Over the course of last year, the CFTC undertook extraordinary efforts to begin to clarify the Commission’s understanding of registrants’ use of AI and the potential benefits and limitations of the Commission’s implementation of AI for supervisory, surveillance, and enforcement purposes. In January of 2024, I worked with Commission staff to issue a Request for Comment distributed to our market participants to better understand the real-time adoption of AI models.[8] Following the Request for Comment, in December of 2024, the Commission issued a staff advisory on Use of Artificial Intelligence in CFTC-Regulated Markets.[9] One of the most significant takeaways from the staff advisory, which was echoed in executive orders issued by the prior administration, underscore the obligation for CFTC-regulated entities to maintain compliance with applicable statutory and regulatory requirements whether they choose to deploy AI or any other technology.

Addressing the Dark Side of AI

While AI has the potential to enhance compliance and supervision, it also introduces new risks. Alongside the promise of AI, we must consider the limitations and potential perils of implementing AI quickly without appropriate guardrails. Many of you in the room today, former Commissioner Berkovitz and Professor Cary Coglianese, among others, have participated in joint studies published by the Administrative Conference of the United States (ACUS) or independently published or presented on these limits. 

In previous speeches, I have outlined concerns regarding the implementation of AI models without effective guardrails and governance interventions. 

In a speech earlier this summer, I began to explore the specific concerns that may emerge as firms and regulators integrate agentic AI.[10] The discussion today, in fact, may largely focus on the integration of agentic AI models in compliance, surveillance, and enforcement. If so, I am hopeful that, in parallel to efforts to explore the benefits, panelists examining “AI’s Role in Regulation Post-Chevron” and “Regulatory Functions Most Amenable to AI-Drive Process Improvement” will also examine important concerns such as the limits of synthetic data, ghosts or hallucinations, data leakage, increasingly undetectable video and voice deepfakes, data accuracy, data security, and data integrity, among others.

Some bad actors are paving the road for regulators and enforcement actions using AI technology. . But, in many cases, the bad actions are simply traditional, garden variety fraud with an AI white-label. 

“AI washing”—the practice of exaggerating or misrepresenting AI capabilities to attract investors or customers[11]—is among the most concerning marketing and solicitation issues that financial market regulators currently face. Firms may claim to use advanced AI models to generate high returns when, in reality, they rely on rudimentary trading bots or nonexistent systems.[12]

Enforcement in Action

The CFTC has actively pursued enforcement actions against fraudulent actors who misuse or misrepresent AI. In a landmark case, the Commission obtained a $1.7 billion penalty—its largest ever—against a South African company that defrauded investors through a fraudulent multilevel marketing scheme.[13] The company falsely claimed to use a proprietary AI trading bot to generate high returns on Bitcoin investments. In reality, there was no proprietary trading bot and the firm engaged in minimal trading activity, most of which was unprofitable, and misappropriated investor funds.

This and other cases underscore the CFTC’s ability to tackle AI-related misconduct using existing legal tools. The Commodity Exchange Act (CEA) provides a robust and flexible framework that prohibits fraudulent and manipulative practices regardless of the underlying technology. For example, CEA Section 4c(a) outlaws disruptive practices such as spoofing,[14] while CEA Section 6(c)(1) and Regulation 180.1 give the Commission broad anti-fraud and anti-manipulation authority.[15] These provisions are intentionally technology-neutral, allowing the CFTC to remain agile as new innovations emerge.

The Commission has demonstrated, through its prior enforcement actions, that markets and market participants engaged in activities that are regulated by the Commission are expected to comply with applicable statutory and regulatory requirements, even when such activities occur with cryptocurrencies or through the use of AI. The technology-neutral approach of the CEA and CFTC regulations allows these provisions to be used to combat fraud in any shape, manner, or form.

The Strategic Importance of Suptech

A recent survey by the Financial Stability Institute (FSI) and the Bank for International Settlements Innovation Hub found that only 3 out of 50 supervisory authorities surveyed did not have ongoing suptech initiatives.[16] Those with a comprehensive suptech strategy were significantly more likely to deploy tools critical to supervision.[17]

This underscores the importance of not only embracing AI on a case-by-case basis, but also developing cohesive strategies for integrating AI into regulatory and supervisory workflows. By investing in data infrastructure, fostering inter-agency collaboration, and recruiting AI-savvy talent, regulators can better equip themselves to meet the demands of increasingly complex markets.

Finding a Pathway Forward

I am looking forward to exploring the following principles and their role in our principles-based regulatory framework that I outlined in a speech last year. [18] As I have previously explained, there are many things that the Commission can do immediately to enhance our understanding of AI and help guide the development of effective guardrails that foster responsible development of AI.[19]

Heightened Penalties

As a CFTC Commissioner, I am also deeply concerned about the potential for abuse of AI technologies to facilitate fraud in our markets. As we examine the development of and limitations on the legitimate uses of AI in our markets, it is also important for the CFTC to emphasize that any misuse of these technologies will draw sharp penalties.

In fact, I continue to call for the Commission to consider introducing heightened penalties for those who intentionally use AI technologies to engage in fraud, market manipulation, or the evasion of our regulations.

In many instances, our statutes provide for heightened civil monetary penalties where appropriate.

I propose that the use of AI in our markets to commit fraud and other violations of our regulations may, in certain circumstances, warrant a heightened civil monetary penalty.

Bad actors who would use AI to violate our rules must be put on notice and sufficiently deterred from using AI as a weapon to engage in fraud, market manipulation, or to otherwise disrupt the operations or integrity of our markets. We must make it clear that the lure of using AI to engage in new malicious schemes will not be worth the cost.

Recommendation for an Inter-Agency Task Force

At the end of 2023, the previous administration announced the creation of an AI Safety Institute, which was to be established within the National institute of Standards and Technology (NIST), housed within the Commerce Department.[20]

Shortly thereafter, I proposed the creation of an inter-agency task force composed of financial regulators including the CFTC, SEC, Federal Reserve, Office of the Comptroller of the Currency, Consumer Financial Protection Bureau, FDIC, Federal Housing Finance Agency, and NCUA to develop guidelines, tools, benchmarks, and best practices for the use and regulation of AI in the financial services industry.[21]

Addressing the perils of AI, while harnessing its promise, is a challenge that will require a whole-of-government approach, with regulators working together across diverse agencies. I continue to advocate for agencies working together to provide their essential experience and expertise to help guide the development of AI standards for the financial industry.

Conclusion

The CFTC, in particular, is well positioned to lead in this space. Its principles-based and technology-neutral approach to regulation allows for flexible oversight that supports innovation while safeguarding market integrity. The Commission’s mission—to foster open, transparent, competitive, and financially sound markets—naturally aligns with the adoption of cutting-edge technology.

AI is no longer a futuristic concept—it is a central feature of modern financial markets. Used responsibly, AI enhances compliance, improves oversight, and enables faster and more effective enforcement. The CFTC’s technology-neutral framework allows it to keep pace with innovation while maintaining essential investor protections and market integrity.

Thanks again for allowing me to share my thoughts with you today. I anticipate you will have an energetic, generative, and thoughtful discussion on the panels and following the presentations this afternoon.

The rapidly evolving geopolitical and geostrategic landscape has heightened the importance of CPEC and the Belt and Road Initiative (BRI), positioning them as key drivers of socio-economic integration and trans-regional connectivity.

These initiatives offer a stabilizing framework amid rising uncertainties in the Middle East, the potential closure of the Strait of Hormuz, growing instability in the Arabian Sea, NATO’s eastward expansion in the Black Sea, US-led encirclement of China in the Asia-Pacific, the strategic race for port control in Latin America and India’s hegemonic ambitions in South Asia. As a result, the global contest over economic corridors has intensified.

Obviously, the CPEC and the Organization of Turkic States (OTS) have immense potential for financial integration, infrastructure development, trade, investment, joint venture and cooperation in qualitative industrialization. Hence both have potential for collaboration which should be tapped in the days to come providing an alternative route in Eurasia and beyond through Gwadar and Karachi dry port and keen interest of all the Central Asian countries mainly Azerbaijan, Uzbekistan, Kazakhstan, Tajikistan and Kyrgyzstan in Gwadar and moreover invitation to Türkiye in CPEC projects vividly reflecting bright prospects of amalgamation of both in the days to come.

Evidently, CPEC emphasizes infrastructure development and economic cooperation between China and Pakistan, while the OTS promotes cooperation among Turkic states across various sectors. It seems that there is potential for synergy in areas like transportation, maritime cooperation, energy & food and trade, particularly as both initiatives involve countries in Central Asia.

Similarly, the BRI aims to establish six main economic corridors. One of these corridors is China Central Asia West Asia Economic Corridor (CCWAEC), which begins in China’s Xinjiang Uygur Autonomous Region and spans 17 West Asian nations, including Iran, Saudi Arabia and Türkiye and five Central Asian nations, namely Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan and Turkmenistan promoting cooperation between the BRI and OTS further diversifying China’s trans-regional connectivity and strategic partnership options.

Additionally, the Central Asian Turkic States hold a strategic position for the BRI which has now entered into its second decade. Interestingly, the OTS which was founded in 2019 concurrently with the emergence of the multipolar world, is composed of Azerbaijan, Kazakhstan, Kyrgyzstan, Uzbekistan and Türkiye as members and Turkmenistan, Hungary and Turkish Republic of Northern Cyprus as observer members. Under BRI, transportation and energy corridors will run across Turkic states in this region consolidating partnership with OTS which is a good omen for both.

Undoubtedly, BRI stands for international cooperation and economic globalization while the OTS is regarded as a significant geostrategic and geopolitical platform. It is predicted that the OTS and its members’ potential collaboration and partnerships with other nations as active participants in BRI will bring about major changes in the international scene.

On the other hand, the increasing cooperation among Turkic states is a strategic regional response to intensifying great power competition and shifting geopolitical dynamics in Eurasia. Moreover, Pakistan’s foreign policy supports bilateral and trilateral cooperation and diplomatic ties with all Central Asian countries along with Türkiye which will create a matching box of CPEC-BRI and the OTS.

According to many published reports the OTS is approximately one-fourth the size of Russia and half the size of China, accounting for around three percent of the world’s total land mass highlighting its geographical importance which may be used for further strengthening of trans-regional connectivity and regional cooperation using CPEC-BRI utility in the days to come. The organization also focused on strengthening transport and energy connectivity, particularly along the Trans-Caspian East-West Corridor and fostered cooperation in areas like trade, investment, green and digital transformation.

In Q1 2025, the aggregate economic output of OTS countries reached approximately USD 593.8 billion, representing 2.1% of global GDP, with a stable average growth rate of 5.04%—more than double the global average of 2.3%—highlighting the region’s vast economic potential. This momentum could be further enhanced through strategic collaboration with CPEC-BRI. Additionally, total trade turnover amounted to USD 369.3 billion, accounting for 4.4% of global trade, underscoring the bloc’s rising trade competitiveness. Key sectors include energy, logistics, manufacturing and agro-exports, where countries like Türkiye, Kazakhstan and Azerbaijan play pivotal roles as transit hubs and export corridors within the evolving Eurasian landscape.

Ironically, Kyrgyzstan achieved an extraordinary 13.1% year on year expansion, fueled by a surge in agricultural output and rising global demand for raw materials. Close behind were Northern Cyprus (6.4%), Uzbekistan (6.8%) and Turkmenistan (6.3%), all supported by strong public investment, resource sector growth and increasing foreign direct investment transforming their economies and communities towards greater prosperity and progress.

Kazakhstan and Uzbekistan led OTS growth through structural reforms, major infrastructure projects, and improved regulations, attracting foreign investment in energy, transport, and manufacturing. Kazakhstan saw 5.6% Q1 growth—its best since 2012—driven by oil and infrastructure. With OTS growth outpacing the global 2.3% average, the region’s economic dynamism and Eurasian relevance continue to rise.

Turkiye, backed by investor confidence and regional integration, highlights the Turkic region’s growing appeal for productive capital, contingent on fiscal and regulatory stability. Meanwhile, green and digital transitions gain traction, with Azerbaijan, Uzbekistan and Kazakhstan leading Q1 2025. Azerbaijan’s COP29-backed Caspian-Black Sea Green Energy Corridor aims to export renewables to Europe using solar, wind and hydrogen resources.

In summary, the write suggests that OTS policymakers should promote trans-regional connectivity with CPEC-BRI to eliminate Trump-era trade wars and shield their societies from Cold War mentalities and potential military misadventures. The global power shift from West to East positions Türkiye—geo-strategically located at the center—as key to regional realignments. As a bridge between Asia and Europe, Türkiye and the OTS are vital to BRI’s success. Turkiye’s potential BRICS membership and SCO Dialogue Partner status—alongside Russia, China, Iran, and others—underscore its growing geopolitical weight. Its deepening ties with Russia and expanding BRI cooperation with China reinforce this. Meanwhile, the U.S. is re-engaging in Central Asia to secure rare earth resources and counter Russia-China influence, which should alert the OTS. Severing China-Europe ties remains central to U.S. policy, making BRI a target. Still, CPEC-BRI–OTS synergy promises a win-win in connectivity, industrial growth, energy and food security, socio-economic integration, trade, investment, and joint ventures.